Leventogiannis K, Gkolfakis P, Spithakis G, Tsatali A, Pistiki A, Sioulas A, Giamarellos-Bourboulis EJ, Triantafyllou K
probiotics with the right strain profile address the underlying microbial ecology at multiple levels simultaneously
GL: Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing review & editing
PlexusDx recommends continuing treatment long-term if discontinuation testing shows rapid appetite return or genetic profiles favor high relapse risk
Key takeaways Regulatory Status: As of April 2026, BPC-157 is classified as a Category 2 bulk drug substance by the FDA prohibited in compounding under Section 503A and 503B